Beiersdorf Aktiengesellschaft — Cyborg Score 6/10

Solid
Household & Personal Products / Consumer Staples

Strategic Profile

The company leverages a heritage dating to 1882 to maintain competitive advantages in two distinct markets: premium/derma cosmetics and specialty adhesives for automotive and electronics. With 22,800 employees globally, Beiersdorf combines brand equity in personal care with high-margin technical solutions, positioned as a defensive consumer staples play with exposure to healthcare and premium beauty trends.

Cyborg Score Rationale

Beiersdorf demonstrates strong brand moats (Nivea dominance), consistent dividends (25-year history), and dual-segment diversification, but faces headwinds from subdued demand, revised 2025 growth guidance, and execution challenges in competitive beauty markets. Recent stock weakness presents valuation opportunity despite near-term uncertainty.

Top Insights

  • Consumer Business segment growth revised downward to 3-4% for 2025 (from 4-6%) due to difficult market conditions and subdued pricing momentum across Europe
  • Strong brand portfolio spanning mass-market (Nivea, Eucerin) to prestige (La Prairie) with Tesa adhesives providing counter-cyclical diversification
  • Technical strength in Q3 2025 with beatings in Eucerin and La Prairie offsetting broader consumer weakness; next earnings March 3, 2026
  • Attractive dividend continuity with €1.00 per share paid in 2025 and 25-year unbroken dividend history; current yield ~0.94%

Named Competitors

  • L'Oréal — Global luxury and mass-market beauty leader
  • Unilever — Diversified consumer goods including skincare brands
  • Procter & Gamble — Multi-category consumer staples with skincare portfolio
  • Tesa Equivalent — Industrial adhesive tape solutions competitor

Recent Developments

  • (August 2025) Beiersdorf lowered full-year 2025 sales growth guidance to 3-4% for Consumer Business, down from previous 4-6% target
  • (December 2025) Investment in skincare startup Melt&Marble indicates continued focus on innovation and emerging beauty trends
  • (January 2026) Upgraded to 'Buy' by Bernstein with ~30% upside to €138 price target; stock recovered 13.68% YTD through early February

Open the full interactive Beiersdorf Aktiengesellschaft report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →